A Pharmacogenomic Study of Candesartan in Heart Failure

This study has been completed.
Sponsor:
Collaborator:
AstraZeneca
Information provided by:
Montreal Heart Institute
ClinicalTrials.gov Identifier:
NCT00400582
First received: November 15, 2006
Last updated: July 20, 2011
Last verified: July 2011
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: April 2010
  Primary Completion Date: April 2010 (Final data collection date for primary outcome measure)